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ABSTRACT
PARN, a poly(A)-specific ribonuclease, binds the
50 cap-structure of mRNA and initiates deadenyla-
tion-dependent decay. Eukaryotic initiation factor
4E (eIF4E) also binds to the cap structure, an inter-
action that is critical for initiating cap-dependent
translation. The stability of various mRNA transcripts
in human cell lines is reduced under conditions of
serum starvation as determined by both functional
and chemical half-lives. Serum starvation also leads
to enhanced cap association by PARN. In contrast,
the 50 cap occupancy by eIF4E decreases under
serum-deprivation, as does the translation of reporter
transcripts. Further, we show thatPARN isa phospho-
protein and that this modification can be modulated
by serum status. Taken together, these data are cons-
istent with a natural competition existing at the 50 cap
structure between PARN and eIF4E that may be regu-
lated by changes in post-translational modifications.
These phosphorylation-induced changes in the inter-
play of PARN and eIF4E may determine whether the
mRNA is translated or decayed.
INTRODUCTION
Post-transcriptional regulation is increasingly recognized as a
critical control point in gene expression. Modulation of mRNA
stability can affect the steady-state levels of transcripts without
any change in transcription rate (1,2), permitting rapid res-
ponses to metabolic or cell cycle events. Additionally, a num-
ber of factors have been identified, which can alter the levels of
translation, such as mRNA secondary and tertiary structure,
association of 30 untranslated region (UTR) and 50UTR-RNA
binding proteins, and the phosphorylation of critical proteins
(3–6).
The major decay pathways for mRNA species in eukaryotes
initiate with deadenylation, followed either by decapping and
50–30 exonuclease digestion, or by 30–50 exonuclease decay
(7–9). Recent reports have indicated that this initial, often
rate-limiting step can be performed in mammalian cells by
a poly(A)-specific ribonuclease (PARN) (10), an enzyme with
affinity for the 50 cap structure (11–13). PARN is the best
characterized deadenylase in mammalian cells (13) and is
an enzyme with homology to the RNase D family (14,15).
It is not certain whether PARN is the major deadenylase, as
other enzymes with deadenylating activity have been identi-
fied. However, deadenylation of poly(A) tails by PARN pro-
duces characteristic decay intermediates of 30 nt that
correspond to the sequential removal of poly(A) binding pro-
tein (PABP) molecules, a pattern of deadenylation that has
been observed in cytoplasmic extracts (10). Data indicate that
PARN is constitutively expressed in most mammalian tissues,
located in both the nucleus and cytoplasm (14,16) and is pred-
icted to contain an RNA recognition motif (RRM) and an R3H
domain. The R3H domain is a conserved sequence motif,
identified in >100 proteins, which is thought to be involved
in polynucleotide binding, including double and single-
stranded DNA and RNA (http://bioinfo.weizmann.ac.il/
cards-bin/carddisp?PARN&search=parn&suff=txt).
The two termini of most mammalian mRNAs are character-
stically modified with a m7G(50)ppp(50)N cap at the 50-end and
a poly(A) tail at the 30-end. These modifications occur
co-transcriptionally and are believed to function in protecting
against transcript decay, as well as stimulating translation. The
50 cap structure is the recognition element for translation initi-
ation factor eIF4E. Various reports suggest that the binding
affinity of this protein for the cap may be enhanced by its
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interaction with eIF4G, creating a functional eIF4F complex
(17,18), the formation of which is essential for appropriate
translation of the vast majority of eukaryotic mRNAs.
Furthermore, 50 and 30 termini communicate to facilitate the
efficient translation initiation through interaction of PABP
with the translation initiation factor eIF4G (19). During
the process of mRNA decay, PARN has been shown to interact
with 50 cap in a manner that increases the processivity of
poly(A) tail shortening (8–10). Therefore, it appears that for
both the process of degradation and that of translation, the 50
and 30 termini of mRNA must be brought into close proximity
to effectively perform either process. This suggests that the 50–
30 interactions may be a pivotal control point that determines
the mRNA fate.
Previous studies have indicated that it is unlikely that eIF4E
and PARN can bind simultaneously to the 50 cap (11,12). It is
therefore an intriguing possibility that competition for cap-
binding between PARN and eIF4E could regulate the fate of
mRNA species in the cell, promoting degradation or transl-
ation, respectively. To investigate this hypothesis, we needed
to subject cells to conditions that would be predicted to perturb
this competition. There have been sporadic reports that deple-
tion or withdrawal of nutrients (amino acids or serum) from
cultured cells can induce rapid degradation of various mRNAs
(20–26). Our experimental approach, therefore, focuses on
serum-deprivation and investigates the associated effects on
cap occupancy and transcript fate.
In this study, we report a significant increase in PARN
association with the 50 cap under conditions of serum starva-
tion. This PARN–cap interaction is directly associated with an
increase in the observed mRNA decay rate under serum-
starvation conditions. Changes in the phosphorylation state
of eIF4E and 4E-BP-1, which would reduce the cap occupancy
by the eIF–4F complex, occur concomitantly under serum-
starvation conditions. PARN was also shown to be a phospho-
protein whose post-translational modification is also affected
under serum-starvation conditions. These data suggest that
phosphorylation changes that occur during serum starvation
may be responsible for the observed increased mRNA decay
rates by promoting cap–PARN interactions.
MATERIALS AND METHODS
Tissue culture
Human liver Hep G2 cells were cultured (37C, 5% CO2)
in Eagle’s modified essential medium supplemented with
10% (v/v) fetal calf serum, non-essential amino acids and
2 mM L-glutamine. Serum starvation was induced by culturing
cells in serum-free medium for 15 h prior to experimentation.
Half-life determination of endogenous transcripts by
northern analysis
Time courses were performed after transcription inhibition by
actinomycin D (act D; 5 mg/ml1 final), a treatment that has
been previously shown to inhibit >94% of cellular transcript-
ion in Hep G2 cells (27). Total RNA was extracted from 4 · 106
cells using 1 ml of TRIzol reagent (Invitrogen), every 24 h
over a 96 h time-course. Northern blot analysis and probe
production for b-actin and 18S rRNA were as described previ-
ously (27). For glutamate dehydrogenase (GDH), the template
was generated by PCR using forward primer 50-GATGCAT-
CATGGCTGA-30, reverse primer 50-AGCAAGCAACT-
GACTGCTCT-30 and the following profile: 95C for 4 min,
35 cycles of 95C for 1 min, 55C for 1 min and 72C for 3 min
with a final extension of 72C for 8 min to produce a 335 bp
fragment. All probes were radiolabelled using random hexa-
mer primers and [a-32P]dCTP (GE Healthcare, Amersham
Biosciences), as described previously (27). Resulting bands
were visualized (PhosphorImager, Molecular Dynamics),
quantified (ImageQuant, GE Healthcare, Amersham Bio-
sciences) and b-actin and GDH values were corrected by
comparison to the corresponding 18S rRNA value.
DNA Templates for in vitro transcription
Templates were generated by PCR using a forward primer that
contains a phage SP6 RNA polymerase consensus promoter
sequence (primer 1, 50-CAAGCTATTTAGGTGACAC-30)
and reverse primers that introduce A40 tails on the resulting
RNA (primer 2, 50-T40CAGGTAAACTGG-30, primer 3, 50-
T40ACAATAGCTAAGAATTTC-3
0). PCR was performed
with final concentrations of 1.5 mM MgCl2, 200 mM
dNTPs, 50 pmol of each primer, 1· reaction buffer IV (AB
Gene), and 2 U of DNA polymerase (AB Gene). DNA temp-
lates for these reactions were (i) pGEM–Luc (Promega) for
luciferase (in conjunction with primers 1 and 3 at 50C);
(ii) pGEM–Luc with the 30UTR substituted from cytochrome
c oxidase subunit IV (COX 4) (28) generated as described in
(29), amplified with primers 1 and 2 at 59C for Luc–COX;
(iii) Clones 84 and 12 were selected for their increased stab-
ility as described in (29). Both contain the COX 4 30UTR with
differing 50 nt insertions and were amplified with primers
1 and 2 at 59C; and lastly (iv) Luc-50 insertion was generated
to introduce a stem loop into the 50 UTR upstream of the
luciferase open reading frame by HindIII and BamH1 excision
from pJ6, (30), ligation into HindIII and BamH1 digested
pGEM–Luc and amplified with primers 1 and 3 at 50C.
All PCR reactions were hot start initiated with the following
profile: 95C for 4 min, then 35 cycles of 95C for 1 min,
hybridization for 1 min at specified temperatures, 72C for
3.5 min, and a final 72C for an 8 min step.
In vitro transcription
All in vitro transcription was by high yield bacteriophage
SP6 RNA polymerase in the absence or presence of
m7G(50)ppp(50)G cap analogue (Epicentre). RNA was analysed
for integrity and concentration by denaturing gel electrophor-
esis and rabbit reticulocyte lysate (nuclease treated, Promega)
as described earlier (29).
Functional half-life calculation of luciferase
mRNA and protein
In vitro transcribed, capped RNAs were electroporated into
5 · 106 Hep G2 cells as described previously (29). Briefly,
cells were incubated in 0.5 ml of phosphate-buffered saline
(PBS)/1.25% (v/v) dimethyl sulfoxide on ice before electro-
poration with 5–8 mg of RNA in a Biorad GenePulser II at
400 V/250 mF (0.2 cm pathlength cuvettes). Aliquots of cells
(0.5 · 106) were lysed (cell culture lysis reagent, Promega) at
various time points post electroporation and the luciferase
activity was measured (luciferase assay reagent, Promega).
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Relative light units were plotted as a function of maximal
activity against the time from which functional half-lives
were derived (31). The half-life of the luciferase protein
was determined by cycloheximide addition (100 mg.ml1
final) 90 min post electroporation and the lysates were ana-
lysed at the times indicated.
Chemical half-life calculation of electroporated
mRNA by quantitative RT–PCR
Total RNA was extracted (TRIzol, Invitrogen) from 4 · 106
cells at various time points post electroporation. Reverse
transcriptions were performed on 10 mg of RNA using a
Superscript first strand synthesis system (Invitrogen) after
priming with random hexamers. Real-time PCR (LightCycler,
Roche) was performed using Taqman (PE Applied Biosystems)
probe technology. Probes and primers were designed using
Primer Express Software (PE Applied Biosystems) for both
luciferase and cytochrome c oxidase 7a-L (COX 7a-L) as a
reference gene. Primer/probe details for luciferase are forward
50-CCTTGTCGTATCCCTGGAAGA-30, reverse 50-GGGCG-
CACCTCTTTCGA-30, probe 50-TTGCAACCGCTTCCCCG-
ACTTCT-30 (71 bp amplicon) and for Cox 7a-L forward
primer 50-GCGGTTGCTGGTCAGTAACA-30, reverse prim-
er 50-GCTTATCGTCCTCTGCCCAAT-30 and probe 50-TGC-
GGAATCTGCTGGCTCTTCGTC-30 (63 bp amplicon).
Luciferase and cytochrome c oxidase amplicons were
generated from the same cDNA sample using the
LightCycler–FastStart DNA Master Hybridization Probes
kit (Roche). Reactions were performed with final concentra-
tions of 0.5 mM primers, 0.1 mM probe and 5 mM MgCl2 in
20 ml volume, and the following profile; 95C for 10 min,
45 cycles of 95C for 5 s and 60C for 20 s. Quantification
was by the relative standard curve method (User Bulletin 2,
ABI 7700 Sequence Detection System). Standard curves were
created for both target and reference using cDNA from T = 0
time point. For each time point, the amount of target and
reference was calculated from linear regression of the appro-
priate standard curve, and target values were divided by their
corresponding references. The values obtained for each
transcript were plotted as percentage luciferase mRNA
remaining versus time, and half-lives calculated from the
slope of best fit. Analyses were performed on a minimum
of three independent experiments with each RNA extraction
reverse transcribed three times per time point (n = 9). For
each time course, the mean mRNA remaining was plotted
against time.
Radiolabel transfer, UV-irradiation and
immunoprecipitation
Uncapped in vitro transcribed RNAs were labelled exclusively
at the a-phosphate of the 50 cap structure using recombinant
guanylyl transferase and [a32P]GTP (3000 Ci mmol1, GE
Healthcare, Amersham Biosciences) in the presence of 0.67
mM S-adenosyl-L-methionine (GE Healthcare, Amersham
Biosciences), 50 mM Tris, pH 7.9, 1 mM MgCl2, 5 mM
KCl and 5 mM DTT for 30 min at 37C. The transcript
was phenol extracted, precipitated and a fraction analysed
on 5% (w/v) polyacrylamide/8 M urea gel.
The S100 extracts were prepared as in (32). For S10
fractions, cells were lysed in cold extraction buffer [20 mM
HEPES–KOH, pH 7.5, 50 mM KCl, 25 mM b-glycerophosp-
hate, 10% (v/v) glycerol, 0.1 mM EDTA and 0.5% (v/v)
NP-40] and passed 7 times through a 21 gauge needle. The
lysate was centrifuged at 10 000 g for 10 min at 4C and the
supernatant retained. Both S100 and S10 preparations were
supplemented throughout with protease inhibitors (1 mg.ml1
antipain, 1 mg.ml1 leupeptin, 1 mM p-aminobenzamidine,
1 mM phenylmethylsulphonyl fluoride (PMSF), 1· Roche
EDTA-free protease inhibitor cocktail and 0.2 mM EDTA)
and phosphatase inhibitors (1 mM sodium fluoride (NaF),
25 mM b-glycerophosphate and 10 mM sodium orthovanadate).
For immunoprecipitations (IP), cap-labelled mRNA
(20–50 fmol) was incubated with either 16 mg of S100
(PARN IP) or 40 mg of S10 (eIF4E IP) supplemented with
1.96 mM EDTA, 2.3% (w/v) polyvinyl alcohol, 0.87 mM
ATP, 17.5 mM phosphocreatine for 5 min at 30C.
Reactions were UV-irradiated on ice (10 min for PARN,
32 min for eIF4E) in a Spectrolinker (Spectronics), before
RNase A/T1 (0.25 U/10 U Ambion) digestion for 30 min at
30C. Subsequent steps were performed as described pre-
viously (12). Briefly, 400 ml of NET2 buffer [50 mM Tris,
pH 7.6, 150 mM NaCl and 0.01% (v/v) NP-40] was added post
RNase digestion and reactions incubated with antisera for 1 h,
rotating at 4C. Interactions were collected using
PANSORBIN (Calbiochem) (1 h, rotating at 4C), washed
and separated by denaturing gel electrophoresis (SDS–
PAGE) [10% (w/v) for PARN, 15% (w/v) for eIF4E]. Products
were visualized by ImageQuant analysis (GE Healthcare,
Amersham Biosciences). Antisera against eIF4E from
three different sources were tested for immunoprecipitation.
The Santa Cruz preparation (Santa Cruz Biotechnology, Inc.)
was the most effective and was therefore used for these
experiments.
m7GTP-Sepharose 4B chromatography
This was modified from Martin et al. (33). Cell extracts
were prepared as described for isoelectric focussing (IEF).
Aliquots (100 mg) of post 600 g supernatant were incu-
bated with 30 ml m7GTP-Sepharose (6 nmol ligand, GE
Healthcare, Amersham Biosciences) for 15 min at 4C.
Beads were washed (20 mM HEPES, pH 7.9, 20% glycerol,
100 mM KCl, 0.2 mM EDTA, 1 mM PMSF and 1 mM
DTT, supplemented with protease and phosphatase inhibi-
tors as described above) before elution of associated pro-
teins with SDS sample buffer and separation by denaturing
gel electrophoresis (10% w/v). Immunoblot analysis was
performed as described below with antibodies to PARN
and eIF4E.
Isoelectric focussing
Cell extracts were prepared in S10 extraction buffer,
supplemented with phosphatase and protease inhibitors (as
above), sheared through a 21 gauge needle and centrifuged
at 600 g. The supernatant was incubated overnight at 4C
with m7GTP-Sepharose 4B (GE Healthcare, Amersham
Biosciences); the beads were collected by centrifugation,
washed, resuspended in IEF buffer [3% (v/v) ampholines,
5% (w/v) CHAPS, 0.9 M b-mercaptoethanol and 6 M
urea], electrophoresed through a 3.5–10 pH gradient
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IEF gel (34), transferred and western blotted with eIF4E
antibodies.
Immunoprecipitation of 32P orthophosphate labelled
PARN
Dynal protein G beads (Dynal ASA) were pre-blocked with
0.1 mg.ml1 BSA in NET2 buffer (12) for 1 h at room temp-
erature, then incubated in 500 ml of NET2 for a further hour
with antisera to PARN (1:100 dilution of antisera kindly
donated by E. Wahle) or without (described as 2 only).
The beads were washed in NET2 buffer, before the addition
of lysate. Cells were cultured in a 25 cm2 flask, washed twice
in supplemented KRH buffer (121 mM NaCl, 4.9 mM KCl,
1.2 mM MgSO4, 0.33 mM CaCl2, 12 mM HEPES, pH 7.4,
50 mM H2NaPO4, 25 mM glucose, 2 mM L-glutamine and
1· non-essential amino acids) and incubated for 1 h at 37C in
2 ml of supplemented KRH lacking serum with 500 mCi of
radiolabelled orthophosphate (PBS11, GE Healthcare,
Amersham Biosciences). Cells were washed in cold TBS,
harvested, resuspended in 500 ml of cold IP buffer (150 mM
NaCl, 1 mM EGTA, 1 mM EDTA, 1.0% (v/v) Triton X-100,
20 mM Tris, pH 7.5, 1 mM PMSF, 1 mM DTT, 10 mM
b-glycero-phosphate, 10 mM NaF and Roche complete
mini EDTA-free protease inhibitors) and lysed (7 passes
through a 21 gauge needle). The lysate was cleared by
centrifugation, equal amounts of protein were added to the
anti-PARN treated and 2 only Dynal beads, supplemented to
400 ml with NET2 buffer and incubated at room temperature
for 1 h. Beads were washed (5 · 1 ml NET2) before elution of
complexes in sample loading buffer [20% (v/v) glycerol, 4%
(w/v) SDS, 250 mM Tris, pH 6.8 and 100 mM DTT]. Samples
were electrophoresed through 10% (w/v) SDS–PAGE and
phosphorylated PARN, visualized by PhosphorImager and
ImageQuant analysis.
Phosphoprotein analysis
Phosphorylated and non-phosphorylated fractions of total cell
lysate were prepared following the manufacturer’s recomm-
endations from both serum-starved and stimulated cells using
the Qiagen PhosphoPurification System (http://www.qiagen.
com/catalog/auto/cget.asp?p=PhosphoProtein_purification_kit).
As recommended, final volumes were concentrated with the
nanosep columns provided and equivalent amounts from both
phosphorylated and non-phosphorylated fractions of starved
and stimulated samples were loaded onto 10% (w/v) and 15%
(w/v) denaturing polyacrylamide gels.
Western analysis
Proteins were separated by SDS–PAGE or IEF and immobilized
by wet (100 V, 1 h) or semi-dry (15 V, 1 h) transfer, respectively
onto PVDF (Immobilon-P, Millipore Corporation) membrane
in 25 mM Tris, 192 mM glycine, 0.02% (w/v) SDS and 15%
(v/v) methanol. Proteins of interest were bound by rabbit poly-
clonal antisera [PARN (kindly provided by the Wormington
and Wahle Laboratories), PABP (a gift of the Morley Labor-
atory)], or antibodies against eIF4E, 4E-BP1, and S6 ribosomal
protein (NEB), eIF4E and eIF4G (Santa Cruz), followed by
HRP-conjugated secondaries and visualized with ECL-plus
reagents (GE Healthcare, Amersham Biosciences).
RESULTS
Endogenous transcripts are less stable under serum
starvation
As a prerequisite to challenging the hypothesis described in the
Introduction, conditions needed to be identified that would
perturb the stability and/or translation of transcripts, allowing
us to measure any concomitant alteration in cap occupancy.
Several reports (20–26) had suggested that nutrient depletion
or withdrawal could result in an increased mRNA turnover.
We therefore initiated our studies by determining the turnover
rates of transcripts encoded by two housekeeping genes in
human Hep G2 and HeLa cells cultured under serum-
starved or stimulated conditions. b-actin is a major cytoarc-
hitectural component, while GDH catalyzes the oxidative
deamination of glutamate in the mitochondrion. Both func-
tions are considered vital, and both proteins are expressed at
fairly constant levels. RNA was extracted from these cells
grown under serum-stimulation or starvation conditions at
various time points following transcription inhibition by
act D and the stability of both b-actin and GDH transcripts
was assessed by northern analyses (Figure 1). Under serum-
stimulated conditions, b-actin mRNA was, as expected, relat-
ively stable with a half-life of >96 h. In serum-deprived cells,
however, its half-life was significantly reduced to 40 h
(Figure 1A). A similar trend was seen with GDH transcripts.
In serum-stimulated Hep G2 cells the mRNA also had a half-
life >96 h, whereas in serum-starved cells this was reduced to
27 h (Figure 1B). In order to discern whether the reduction in
the amount of mRNA found in serum-deprived cells at the
later time points post-act D addition was due to increased cell
death over the control cells, the viability of the cells in both
conditions was assessed. Cell viability was found to be com-
parable at all time points post act-D addition, eliminating this
possibility (data not shown). Therefore we conclude that serum
starvation caused an increase in decay rates of b-actin
and GDH mRNAs.
Serum starvation also decreases half-lives of
exogenous transcripts
By inhibiting transcription with the intercalator act D, we were
able to show that there is a more rapid turnover of certain
endogenous transcripts in serum-starved conditions. It has
been shown, however, that observations with different trans-
cription inhibitors must be carefully interpreted. Harrold et al.
estimated an mRNA half-life using different analytical app-
roaches. They describe how transcription inhibitors act in
different ways and gave different values for the decay rate
of the same transcript. For example, 5,6-dichloro-1-beta-D-
ribobenzimidazole (DRB) blocked RNA polymerase II trans-
cription by >90% but only blocks the accumulation of
non-RNA polymerase II RNA species by 11% (35). DRB
also gave different levels of transcription inhibition in differe-
nt cell types (35). In contrast, act D intercalates into the DNA
inhibiting essentially all transcription. Moreover, act D
prevents transcripts from properly attaching to the ribosome
and thereby affecting translation as well as transcription. They
also observed that the rate of transcript decay was increased in
act D treated cells relative to that observed with DRB (35).
Thus, although the utility of this approach for estimating
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mRNA half-lives may be considered debatable, we were using
the same inhibitor in the same cell type and felt that this
observation was a real and physiological effect. We wished,
however, to confirm our observations in Figure 1 by an inde-
pendent method. By electroporating cells with a reporter
mRNA that cannot be generated by the cell, rates of transcript
decay can be measured directly, obviating the need for any
transcriptional inhibitors. A set of luciferase transcripts that
varied only within a 50 nt cassette positioned in the 30UTR
(29), was electroporated into both serum-stimulated and
serum-starved cells. Functional half-lives were determined
for luciferase transcripts following electroporation in both
starved and stimulated cells. The functional half-life is defined
as the half-maximal value of luciferase activity (31) and the
data are depicted in Figure 2. The trace from the luciferase
transcript population in the starved cells was shifted to the left,
indicating that it was substantially less stable (95 min) than in
stimulated cells (150 min) (Figure 2A, leftmost panel). In
order to determine whether this constituted a generic phenom-
enon or whether it was restricted to a subpopulation, a number
of previously derived luciferase clones, which differed in the
30 UTR, were utilized (29). Four additional luc-variant
mRNAs were assayed to determine their stabilities in
serum-starved and stimulated Hep G2 (Figure 2A) or HeLa
cell lines (data not shown). In all cases, half-lives were red-
uced when cells were serum-deprived, irrespective of 50 or
30UTR composition. In addition, the maximal amount of
translation product was also reduced (as would be predicted
if less eIF4E was binding the cap).
To measure transcript stabilities directly, chemical half-
lives were derived using real time RT–PCR. Quantification
of mRNAs encoding reporter (luciferase) and an endogenous
control transcript (cytochrome c oxidase subunit VIIa, COX
7a-L mRNA) were performed from a single cDNA pool gen-
erated by random hexamer primed reverse transcription. Lucif-
erase transcript levels, as well as two variants containing Cox4
30 UTR sequences, were compared to the control at time points
post electroporation and expressed as percentage luciferase
mRNA that remained. As seen in Figure 2B, the half-lives
of these mRNAs were significantly decreased under serum-
starvation conditions. The absolute values obtained for
chemical versus functional half-lives differed, as reported
previously (31). Importantly, the relative hierarchy of stability
and ratio of starved to stimulated half-life was similar. The
most stable transcript in control conditions, Luc–Cox84
(6.9 – 0.1 hours), had been identified previously as containing
an element within the 30UTR capable of enhancing stability
(29). Despite this, it could not abrogate the loss of stability
Figure 1. The stability of endogenous mRNAs is reduced in serum-starved cells. Hep G2 cells were grown in Eagle’s MEM supplemented with 10% fetal calf serum
(serum-stimulated) or cultured in serum-free media for 15 h (serum starved). Transcription was inhibited by the addition of act D and total RNA was isolated at the
times indicated. Northern blot analysis was performed with probes againstb-actin mRNA and 18S rRNA (A) or GDH mRNA and 18S rRNA (B). Transcript half-lives
were determined from the graphs on the right of the figure. Black diamonds represent serum-stimulated values; open diamonds represent serum-starved samples.
380 Nucleic Acids Research, 2005, Vol. 33, No. 1
under serum starvation (1.8 – 0.01 h). Similarly, Luc transcript
stability decreased from 4.7 – 0.1 to 3.4 – 0.3 h and Luc–COX
from 4.6 – 0.6 to 2.2 – 0.2 h.
Finally, to confirm that changes in the mRNA functional
half-life were not attributable to differences in degradation
rates of reporter protein, cycloheximide was added 90
min post electroporation, and luciferase activity monitored
over time (Figure 2C). Only a minor difference in protein
decay rates was observed (e.g. half-lives of 156 min in
serum-starved Hep G2 cells versus 134 min in serum-
stimulated cells). Similar data was also obtained in HeLa
cells as well (protein half-lives of 200 min in serum-starved
cells versus 210 min in serum-stimulated cells). Therefore, we
conclude that the half-lives of mRNAs, whether the transcripts
are endogenously produced or introduced into the cells, are
significantly reduced under serum-starved conditions.
Occupancy of the 50 cap structure by PARN and
eIF4E is differentially affected by serum starvation
To determine whether the decrease in mRNA stability and
translation could be due to a modulation in cap occupancy,
various luciferase mRNAs (Figure 3A) were used to assess
the interactions between PARN and the 50 cap structure.
Individual transcripts, radiolabelled exclusively at the 50 cap,
were incubated with S100 extracts, irradiated with UV light to
cross link closely associated proteins, and treated with RNase
to effectively transfer short cap-labelled oligomers to the
proteins. Reaction mixtures were immunoprecipitated with
anti-PARN antibodies and separated by denaturing gel elec-
trophoresis (12). Under serum starvation, luciferase transcripts
demonstrated a 3.03-fold increase in occupancy of the cap
structure over stimulated cells, consistent with the observed
loss of stability of the transcript in this condition (Figure 3B,
top panel, lanes 1 and 2). Similarly, Luc–COX transcripts
(substituted 30 UTR sequence) also demonstrated increased
(2.17-fold) PARN association (Figure 3B, top panel, lanes 5
and 6). A luciferase transcript with an insertion of a stem loop
into the 50 UTR (Figure 3B, top panel, lanes 3 and 4) also
showed enhanced binding (2.63-fold). Since protein–RNA
binding reactions were performed in the presence of
EDTA, no significant degradation of the input RNA was
noted under any conditions (data not shown). Therefore, we
conclude that PARN protein in extracts from serum-starved
cells is significantly better at interacting with the 50 cap of an
mRNA substrate.
As there is an increase in PARN/cap interaction in cells
deprived of serum, does this increase occur at the expense
of other cap-binding proteins? The eIF4E is a cap-binding
Figure 2. The stability of electroporated mRNAs is also significantly decreased in serum-starved cells. (A) Five reporter mRNAs containing the luciferase open
reading frame (luc) or luc plus additional sequences in the 30 UTR derived from a random 50mer (luc–N50–30UTR), COX 4 (luc–cox), or two variants of the COX 4 30
UTR (luc–cox84 and luc–cox12) were individually electroporated into serum-starved or serum-stimulated Hep G2 cells. Cells were lysed at the indicated times and
luciferase activity was assessed. Relative luciferase units were plotted as a percentage of maximal activity to approximate functional mRNA half-lives. (B) Levels of
three electroporated mRNAs (luc, luc–cox and luc–cox84) were directly determined by real time PCR and plotted versus time post electroporation on semilog plots to
generate decay curves. (C) The half-life of the luciferase protein under these experimental conditions was assessed by treating cells with cycloheximide 90 min post
electroporation and analysing luciferase enzyme activity at the times indicated. In all three panels, black diamonds represent serum-starved values; open squares
represent serum-stimulated samples.
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protein and, as a crucial member of a functional eIF4F com-
plex, is required for cap-dependent protein translation. Pert-
urbations in the cap–eIF4E interactions were, therefore,
investigated using essentially the same strategy as for
PARN with the same three transcripts. Although the same
panel of radiolabelled transcripts was used, these transcripts
were incubated with an S10 preparation to allow for binding of
the eIF4F complex to the 40S ribosomal subunit. Cap-labelled
RNA fragments that were cross-linked to eIF4E were
immunoprecipitated with anti-eIF4E antisera, and the isolated
complexes separated by denaturing gel electrophoresis. For
each of these three transcripts, the interaction was stronger
(2.17, 3.33 and 2.27-fold, respectively) for serum-stimulated
(Figure 3B, lower panel, lanes 2, 4 and 6), than serum-deprived
cells (Figure 3B, lower panel, lanes 1, 3 and 5). Therefore, it
appears that one contributing factor to the increase in cap
occupancy observed in serum-starved extracts may be a dec-
rease in cap binding activity of the endogenous eIF4E fraction.
In order to further support these observations through an
independent assay, cap binding was also assessed by
interaction with immobilized cap analogue (m7GTP-
Sepharose 4B). Cell lysates were prepared and aliquots
(100 mg) were incubated with m7GTP-Sepharose 4B. Intera-
cting proteins were separated by 10% (w/v) SDS–PAGE and
analysed by western blotting with antibodies to PARN or
eIF4E. As seen in Figure 3C, an increased interaction was
observed with PARN in starved compared to stimulated cell
extracts (63% – 4.4 of starved sample), while association with
eIF4E was decreased (49.5% – 3.2 of stimulated sample). It
must be stressed that each of the samples loaded on to the gel
represented in Figure 3C lane 1 or 2 constitute the entire
complement of protein capable of binding to the 7MeGTP
beads. The signals derived from the subsequent western
blot that was probed specifically for PARN and eIF4e strongly
reinforces that these interactions appear reciprocal. These
data, therefore, suggest that there is an decreased interaction
of eIF4E with 50 cap structures of transcripts in extracts from
serum-starved cells, giving greater accessibility to PARN. The
reduction in eIF4E interaction may also, in part, be responsible
for the diminished levels of translation under these conditions.
Figure 3. Serum starvation differentially affects the interaction of PARN and eIF4E with the mRNA 50 cap. (A) Diagrammatic representation of the luciferase mRNA
and its two variants used in this study. SL–Luc had a stem loop structure inserted into its 50 UTR. Luc–Cox contained the COX4 30 UTR attached to the luciferase
opening reading frame. All constructs were capped and contained a 40 base adenosine 30 tail. (B) The RNAs outlined in panel A were labelled exclusively at their 50
cap structure and incubated in cell extracts derived from serum-stimulated (stimulated lanes) or serum-starved cells (starved lanes). Reactions mixtures were
irradiated with UV light to covalently cross-link closely associated proteins and treated with RNase. Samples were then immunoprecipitated usinga-PARN (top half)
ora-eIF4E (bottom half) antisera. Immunoprecipitated proteins that were cross linked to the radioactive cap were separated on polyacrylamide gels containing SDS,
visualized by phosphorimaging and analysed using ImageQuant software. (C) Post 600 g supernatants prepared from cells grown under serum-starvation conditions
(starved lanes) or in the presence of 10% serum (stimulated lanes) were incubated with m7GTP-Sepharose beads. Beads were washed extensively and bound proteins
were electrophoresed on a 10% polyacrylamide gel with SDS. Western blots were performed to assess the levels of bound PARN (top half) and eIF4E (bottom half)
using specific antisera.
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Steady-state levels of proteins that interact at transcript
termini do not differ between serum-starved and
stimulated conditions, but differences in
post-translational modifications are evident
The changes in relative cap occupancy between PARN and
eIF4E noted above could be due to changes either in overall
protein levels or in the overall activity of the available pro-
teins. To determine whether the increase in PARN-cap occ-
upancy in serum-starved cells was due to an increase in overall
levels of this protein, western analyses were performed.
As seen in Figure 4, the steady-state level of PARN was
unchanged between serum-starved and stimulated cells in both
S10 and S100 extracts. No difference in the level of the cap-
binding protein eIF4E, the least abundant of the initiation
factors (36), could be detected. The amounts of translationally
related proteins that compete for a binding site on eIF4E, such
as eIF4G or 4E-BP1 (17,37), were also assessed. Western
analyses shown in Figure 4 revealed no detectable differences
in the levels of these proteins between the serum-starved and
stimulated cells. Finally, as a decrease in PABP coating the
poly(A) tails could increase the accessibility for PARN and
potentially enhance mRNA degradation, steady-state levels of
PABP were compared in serum-starved versus stimulated
cells. A slight decrease in serum-starved cells was noted
(68% – 8 n = 7). This observation is consistent with the
repressed translation of PABP seen under conditions of growth
arrest in mouse fibroblasts (38).
Serum-stimulation has been shown to induce phosphoryl-
ation of eIF4G, 4E-BP1 and eIF4E (39–41). To confirm this in
our system, the levels of phosphorylation of various proteins
were assessed. Samples of total protein were separated by
isoelectric focussing and eIF-4E levels were assessed by
western blotting. As seen in Figure 5A, eIF4E from serum-
starved cells showed a decrease in overall phosphorylation
compared to serum-stimulated cells. Next, cell lysates were
separated on an SDS–PAGE gel and western blots were probed
with anti-4E-BP1 antisera that recognized pSer65 of 4E-BP1.
As seen in Figure 5B, the proportion of phosphorylated
4E-BP1 was decreased in serum-starved cells. Similar results
Figure 4. Serum starvation does not significantly alter the levels of PARN or
translation initiation factors associated directly or indirectly with the cap. Hep
G2 cells were grown in Eagle’s MEM supplemented with 10% fetal calf serum
(stimulated lanes) or cultured in serum-free media for 15 h (starved lanes). Total
protein from S10 or S100 fractions was prepared and electrophoresed on poly-
acrylamide gels containing SDS. Western blotting was performed with the
indicated antisera to detect PARN, eIF4E, eIF4G, PABP and 4E-BP1. Proteins
were visualized with ECL reagents.
Figure 5. Phosphorylation of eIF4E and 4E-BP1 is impaired in serum-starved
cells. Hep G2 cells were grown in Eagle’s MEM supplemented with 10% fetal
calf serum (stimulated lanes) or cultured in serum-free media for 15 h (starved
lanes). (A) Cap binding proteins were purified on m7GTP-Sepharose 4B beads
and electrophoresed through a 3.5–10 pH gradient isoelectric focussing gel.
Western blotting was performed usinga-eIF4E antisera. (B) Proteins from S10
or S100 cellular fractions prepared from Hep G2 cells grown under the indicated
conditions were electrophoresed on a 15% polyacrylamide gel containing SDS.
Phosphorylated 4E-BP1 binding protein was specifically detected by western
blotting with antisera to the ser65 phosphorylated isoform.
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were obtained using 5 or 10 mg of the extract, confirming the
quantitative nature of our assays. We conclude that the
phosphorylation of eIF4E and 4E-BP1 is decreased under
serum-starvation conditions. Based on the known properties
of the dephosphorylated isoforms of these proteins (1), this is
likely to be responsible for the decrease in cap occupancy that
was observed for eIF4E in extracts prepared from serum-
deprived cells.
PARN is a phosphoprotein with different
phosphorylation profiles under serum-starved
and stimulated conditions
As the increased cap occupancy by PARN in serum-starved
cells could not be explained by increased steady-state levels,
we evaluated differences in post-translational modifications.
Using the NetPhos 2.0 Prediction programme (http://
www.cbs.dtu.dk/services/NetPhos/), multiple serine, threon-
ine and tyrosine residues within PARN were predicted to
be potential sites for phosphorylation. To determine whether
PARN was indeed phosphorylated in vivo, label transfer exp-
eriments were performed. Cells were cultured in the presence
of radiolabelled orthophosphate, lysed, immunoprecipitated
with a-PARN antisera and complexes were analysed by
SDS–PAGE. Phosphorylation of PARN was clearly evident
(Figure 6A), indicating that it is indeed a phosphoprotein. To
establish a physiological relevance to the phosphorylation of
PARN, preparations of starved and stimulated cells were sub-
jected to separation using the Qiagen PhosphoProtein Purifica-
tion System. Equal proportions of phosphoproteins and
non-phosphorylated fractions were separated by SDS–
PAGE. Data resulting from western analysis not only suggest
that PARN is indeed a phosphoprotein, but also indicate that
the ratio of non- to phosphorylated protein is modulated by
serum. Starved cells demonstrate a greater proportion of
phosphorylated PARN, in contrast to stimulated conditions
(Figure 6B). To confirm the quality of the separation of phos-
phorylated isoforms, immunodetection was performed with a
number of antisera specific for phosphoproteins, as well as
proteins known not to contain phosphate (Figure 6B).
Antibodies that recognize phosphoserines at position 65 of
4E-BP1 and 235/236 of the S6 ribosomal protein only detected
protein in the phosphorylated fractions as expected (Figure 6B).
In contrast, GDH, which is not known to be phosphorylated,
was found exclusively in lanes corresponding to non-
phosphorylated fractions (Figure 6B). Thus, it appears that
PARN is a phosphoprotein and that this modification appears
to be modulated by physiological growth conditions.
DISCUSSION
We have shown that serum deprivation of cultured cells causes
a more rapid turnover of various endogenous and electro-
porated transcripts. In these serum-starved culture conditions,
transcript populations that were more rapidly degraded also
had more PARN bound to the 50 cap. An increase in
PARN cap-occupancy has been shown previously to reflect
increased deadenylation activity (12). Conversely, cap-
occupancy by eIF4E was reduced, consistent with the obs-
erved reduction in translation of these reporter mRNA species
(despite equivalent electroporation efficiency), suggesting the
loss of a functional eIF4F. Our data also demonstrate that
PARN is a phosphoprotein, with this modification being
modulated by serum conditions. PARN phosphorylation
was increased in serum-deprived cells, whereas the phosphor-
ylation of both eIF4E and its cognate binding protein 4E-BP1
was diminished under the same conditions. Taken together,
Figure 6. PARN is a phosphoprotein. (A). Hep G2 cells were cultured in the presence of 32P orthophosphate for 60 min. Lysates were prepared and
immunoprecipitated using a-PARN sera (a-PARN lane) or protein G alone (control lane). Immunoprecipitated proteins were analysed on a 10%
polyacrylamide gel containing SDS and detected by phosphorimaging. (B) Total cell lysates from Hep G2 cells grown under serum-stimulated (lanes 1 and 2)
or starved (lanes 3 and 4) conditions were separated into phosphorylated (lanes 1 and 3) and non-phosphorylated (lanes 2 and 4) fractions using the Qiagen
phosphoprotein purification system. Fractions were electrophoresed on polyacrylamide gels containing SDS and the levels of the indicated proteins [PARN, known
phosphoproteins (4E-BP1 and S6 ribosomal protein) and unphosphorylated GDH] were detected by Western blotting. The ratio of phosphorylated PARN appears to
be modulated by serum status.
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these data are consistent with the equilibrium between mRNA
deadenylation and translation, being modulated by a competi-
tion for the 50 terminal cap between PARN and eIF4E, a
competition that may be regulated by phosphorylation of
these factors. A model outlining these observations is pre-
sented in Figure 7.
Although these data are internally consistent, it must be
considered that there are other proteins that can bind to the
50 cap, in addition to PARN and eIF4E. The binding of YB-1
protein, for example, has been reported to cause the stabiliza-
tion of mRNA (42) and may compete with eIF4E. However,
YB-1, which can be localized to the nucleus or cytoplasm (43),
has sequence selectivity for certain mRNAs (44) and the red-
uced stability of mRNA in serum-deprived cells suggests that
YB-1 is not bound at high levels to the 50 cap in this condition.
To further refute the possibility that we were observing an
artefact, the stability of endogenous transcripts was also
measured and was shown to decrease in response to serum-
deprivation. b-actin and GDH transcripts had shorter half-
lives in serum-starved Hep G2 cells. This is consistent with
earlier work by Levy and Hug who noted that b-actin trans-
cripts were less stable in quiescent- compared to proliferating
Hep G2 and MCF-7 cells (20) and in a rat liver cell line
deprived of amino acids (21), under conditions wherein
other mRNA species were also shown to be more rapidly
degraded. There are many other reports of serum or amino
acid deprivation causing increased rates of decay for numerous
endogenous transcripts in immortalized or primary cell lines
(22–26). These experiments, however, did not address the
mechanisms of increased mRNA decay. Noe et al. assessed
transcript stability using a tetracycline responsive dihydrofol-
ate reductase (DHFR) minigene introduced into CHO cells
(45). Not only was the half-life of the DHFR mRNA decreased
under serum starvation but this was accompanied by poly(A)
tail shortening. Taken together with our data presented here,
we propose that the decreased half-life observed in the DHFR
minigene (and a subset of endogenous transcripts) under cond-
itions of nutrient deprivation is a consequence of increased
interaction of PARN, thereby enhancing deadenylation-
dependent decay.
Gallie and Traugh previously postulated that cap-associated
factors may be serum sensitive and that serum may affect the
function of the cap and the activity of factors associated with it
(46). The authors electroporated transcripts with and without a
50 cap and/or poly(A) to investigate the synergism of cap and
poly(A) tail on mRNA stability in response to insulin. Prior to
insulin stimulation, cells were serum-deprived for 90 min and
a small but consistent decrease in mRNA stability along with a
decreased rate of translation, was observed. The effects in
starved cells were more subtle than those described here,
but this may relate to the duration of serum deprivation.
They concluded that the accelerated mRNA decay was due
to a modification of eIF4F in light of the rapid change in
phosphorylation of eIF4E on serum addition. At the time of
their work, PARN had not yet been identified. However, their
observations and conclusions support the data presented here.
Serum status does affect the complement of proteins bound to
the 50 cap such that deprivation increases the proportion of
PARN bound and decreases association of eIF4E, leading to a
reduction of cap-dependent translation. In contrast, serum
stimulation favours cap interaction with eIF4E over PARN
and enhances cap-dependent translation.
Our experiments show that more PARN is bound to the 50
cap on serum withdrawal, yet there is no obvious increase in
the steady-state level of the protein. Ko¨rner and et al. (14) have
demonstrated that PARN is distributed between the nuclear
and cytoplasmic compartments. This partitioning plays a
Figure 7. Schematic representation of changes in RNA–protein interactions
and protein–protein assemblies on transcripts as a consequence of serum star-
vation or stimulation. This simplified diagram represents some of the known
interactions at the 50-terminus during cap-dependent translation of mRNA
under serum-stimulated culture conditions. (A) When cells are stimulated
by serum, there is a greater proportion of mRNA with eIF4E at the 50 cap,
resulting in a functional eIF4F complex that interacts with PABP at the 30
terminus. This interaction protects both the 50 cap and poly(A) tail from inter-
action with PARN. Serum stimulation causes phosphorylation (indicated by
black dots) of eIF4E, its cognate binding proteins and eIF4G. The latter acts as a
binding site for Mnk1, the kinase responsible for phosphorylation of eIF4E.
This reflects our data in stimulated cells that show increased eIF4E-cap binding
and higher levels of cap-dependent translation. (B) In contrast, our data show
that cells deprived of serum favour interactions with PARN at the 50 cap and this
protein may be hyperphosphorylated, increasing the association with mRNA.
This interaction appears to be at the expense of eIF4E binding and is consistent
with the diminished cap-dependent translation in serum-deprived cells
described here. A model of PARN cap-binding kinetics has been proposed
by Virtanen et al. in which a single PARN molecule binds the cap, while a
trimer generates the poly(A)-binding site and an active deadenylation complex
(10). The competition between eIF4E and PARN may be regulated by further
physiological changes and could represent a key mechanism in the balance
between translation and degradation of transcripts.
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crucial role in Xenopus oocytes, such that PARN is retained in
the nucleus and is not released into the cytoplasm until meios-
is. Thus, any alterations in this nuclear–cytoplasmic partition-
ing could provide a potential mechanism by which changes in
PARN deadenylation are regulated. We compared PARN in
the nuclear and cytoplasm under both growth conditions but
found no difference in distribution (data not shown).
Although there were no changes in steady-state amounts or
cellular distribution of either PARN or eIF4E, we were able to
show that the phosphorylation state of both factors is modul-
ated by serum status. Previous research has also shown that
hypophosphorylated 4E-BP1, which is prevalent in serum-
deprived cells, has an increased affinity for eIF4E, resulting
in a decreased interaction of eIF4E with eIF4G, a concomitant
decrease in eIF4F complex assembly and cap-dependent
translation (47). Moreover, the affinity of eIF4E for the 50
cap is reported to be increased as a result of the interaction
between the eIF4F complex and PABP (48,49), an interaction
that also increases the affinity of PABP for the poly(A) tail.
This interaction decreases in serum-deprived cells (50), expos-
ing both the 50 cap and the poly(A) tail to PARN. Similarly,
PGK1 mRNA stability is decreased in yeast expressing mutant
forms of eIF4E and eIF4G1 (51), consistent with the release of
these factors exposing transcripts to enhanced degradation.
Binding of 4E-BP1 to eIF4E has also been shown to block
phosphorylation of eIF4E (52). Although these results are
consistent with our observations of phosphorylation and decre-
ased translation under serum starvation, there are conflicting
data as to whether phosphorylation of eIF4E modulates cap-
binding (53–55) or control of translation (56,57). Decreased
cap interaction by eIF4E for whatever reason, however, would
allow increased access for PARN.
In conclusion, it is clear that various mechanisms operate
post-transcriptionally to regulate both the steady-state levels
of mRNA and their translation. Availability of mRNA tem-
plate will dictate the levels of translation, as will events such as
phosphorylation, which will affect the assembly and function
of eIF4F. A wealth of previously published observations, some
of which have been referenced here, describe decreases in
either transcript levels and/or translation under nutrient
deprivation and, conversely, enhancement when stimulated
with nutrients, serum or hormones. Taken together with our
data presented here, we suggest that a major post-
transcriptional mechanism that controls the expression of at
least a subset of transcripts is dependent upon the competition
of PARN and eIF4E for the 50 cap, as presented in Figure 7.
Under conditions of nutrient deprivation, the cap interactions
of eIF4E decrease in favour of PARN, potentially driven by
the changes in phosphorylation states of these proteins them-
selves or their cognate binding proteins, shifting the balance
away from cap-mediated translation, and critically increasing
the deadenylation-dependent decay of transcripts.
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